Company news
Sareum Holdings Plc (LSE:SAR) news
Sareum Holdings Plc news releases on 6ix. Latest, Aug 6, 2021: SRA737 update
Press releases — page 3
SRA737 update
August 6, 2021
US Patent Notice of Allowance for SDC-1802
July 30, 2021
Exercise of Warrants and Total Voting Rights
July 14, 2021
Covid-19 Research Project Results
July 1, 2021
Sareum to Present at BioTrinity 2021 Conference
June 21, 2021
Subscription to raise £1,470,000
June 15, 2021
Subscription to raise £900,000
June 1, 2021
Exercise of Options and Total Voting Rights
May 13, 2021
Sareum Holdings (SAR): Treading the TYK2 trail
May 5, 2021
Research Update
March 25, 2021
Interim Results Extension
March 25, 2021
Sareum Notes New UK Government Covid-19 Initiative
February 16, 2021
Sareum to Present at the LSX World Congress 2021
February 1, 2021
Sareum to Participate in the Edison Open House
January 26, 2021
Update re: FLT3+Aurora Kinase Inhibitor Programme
January 8, 2021
US Patent Grant for TYK2/JAK1 Anticancer Candidate
January 7, 2021
Nature article highlights role of TYK2 in Covid-19
December 14, 2020
Covid-19 Research Grant Confirmed
December 3, 2020
Update on SRA737 Licensing Agreement
November 12, 2020
Notification of Grant Award for Covid-19 Research
October 27, 2020
Full Year Results Investor Presentation
October 13, 2020
Final Results
October 13, 2020
US Patent Allowance: SDC-1802 TYK2/JAK1 Inhibitor
October 8, 2020
Details of Investor Presentation
August 12, 2020
Update on Deferred Salaries and Issue of Equity
July 1, 2020
Successful Fundraising
June 3, 2020
PrimaryBid.com Offer
June 2, 2020
Placing to raise £718,500
June 2, 2020
Sareum to Present at BIO Digital 2020
May 27, 2020
BioTrinity Presentation Available Online
May 1, 2020
Company Presentation at BioTrinity
April 28, 2020
Global Licensing of FL3+Aurora Programme
March 26, 2020
Publication: new SRA737 combinations in cancer
March 12, 2020
Sareum notes Sierra Oncology Q3 2019 results
November 5, 2019
Research Update - SDC-1802 anti-cancer poster
October 30, 2019
Research Update - AACR-NCI-EORTC abstract
October 17, 2019
Notice of Full Year Results
October 7, 2019
Research Update - TYK2/JAK1 cancer programme
September 27, 2019
Change of Adviser
August 16, 2019
Sareum notes Sierra Q2 results
August 8, 2019
Additional disclosure concerning Michael Owen
July 29, 2019
Additional Funds Raised
June 28, 2019
Sierra seeks strategic options for SRA737
June 27, 2019
Placing to progress TYK2/JAK1 programmes
June 25, 2019
Portfolio Update
June 13, 2019
Key takeaways from SRA737 webcast at ASCO
June 3, 2019
Positive SRA737 data presented at ASCO
June 3, 2019
ASCO abstracts for SRA737 published
May 16, 2019
Sareum notes Sierra Oncology Q1 2019 Results
May 8, 2019
Sareum to Present at BioTrinity 2019 in London
April 30, 2019